{"url_path":"/sec/mtne/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/2044817/0001193125-26-269963-index.html","accession_number":"0001193125-26-269963","cik":"0002044817","ticker":"MTNE","issuer_name":"CH4 Natural Solutions Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/2044817/0001193125-26-269963-index.html","primary_entity_key":"0002044817","primary_entity_name":"CH4 Natural Solutions Corp"},"word_count":1116,"has_tables":true,"body_markdown":"10-Q\n\n##### Table of Contents\n\nfalseQ1--12-310002044817NYThis number excludes an aggregate of 1,000,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full by the underwriter. On May 6, 2026, the underwriter partially exercised the over-allotment option and on May 8, 2026, purchased 2,000,000 units under the over-allotment option, reducing the shares subject to forfeiture to 333,333. The underwriter has until 45 days from the date of the Company’s Prospectus dated April 30, 2026 (the “Prospectus”) to exercise the remaining 1,000,000 units under the over-allotment option. (see Note 4).In November 2025, the Company effected a share dividend with respect to the Company’s founder shares of 4,312,500 shares thereof, resulting in the Sponsor owning an aggregate of 11,500,000 founder shares. On April 22, 2026, our sponsor surrendered to us for no consideration an aggregate of 3,833,333 founder shares, which we accepted and canceled, resulting in our sponsor owning 7,666,667 founder shares for approximately $0.003 per share, due to the changes in the offering size. All share and per-share data have been retrospectively presented.This number includes an aggregate of 1,000,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full by the underwriter. On May 6, 2026, the underwriter partially exercised the over-allotment option and on May 8, 2026, purchased 2,000,000 units under the over-allotment option, reducing the shares subject to forfeiture to 333,333. The underwriter has until 45 days from the date of the Company’s Prospectus dated April 30, 2026 (the “Prospectus”) to exercise the remaining 1,000,000 units under the over-allotment option. (see Note 4). 0002044817 2026-01-01 2026-03-31 0002044817 2025-01-01 2025-03-31 0002044817 2026-03-31 0002044817 2025-12-31 0002044817 2024-12-31 0002044817 2025-03-31 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-05-06 2026-05-06 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-06 2026-05-06 0002044817 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-06 2026-05-06 0002044817 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-05-06 2026-05-06 0002044817 us-gaap:SubsequentEventMember 2026-05-06 2026-05-06 0002044817 us-gaap:CorporateMember 2026-01-01 2026-03-31 0002044817 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002044817 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2026-01-01 2026-03-31 0002044817 mtne:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOneHalfOfOneWarrantMember 2026-01-01 2026-03-31 0002044817 mtne:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember 2026-01-01 2026-03-31 0002044817 us-gaap:CapitalUnitClassAMember 2026-01-01 2026-03-31 0002044817 mtne:UnitsMember us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0002044817 mtne:LoanMember mtne:SponsorMember 2026-01-01 2026-03-31 0002044817 srt:MaximumMember 2026-01-01 2026-03-31 0002044817 srt:MinimumMember 2026-01-01 2026-03-31 0002044817 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2025-01-01 2025-03-31 0002044817 us-gaap:CorporateMember 2025-01-01 2025-03-31 0002044817 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002044817 us-gaap:CommonClassAMember 2026-03-31 0002044817 us-gaap:CommonClassBMember 2026-03-31 0002044817 us-gaap:CorporateMember 2026-03-31 0002044817 us-gaap:PreferredStockMember 2026-03-31 0002044817 mtne:UnitsMember us-gaap:PrivatePlacementMember 2026-03-31 0002044817 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-03-31 0002044817 mtne:LoanMember mtne:SponsorMember 2026-03-31 0002044817 mtne:PromissoryNoteMember mtne:SponsorMember 2026-03-31 0002044817 mtne:SponsorMember 2026-03-31 0002044817 us-gaap:IPOMember 2026-03-31 0002044817 mtne:PostBusinessCombinationCompanyOwnsOrAcquiresMember 2026-03-31 0002044817 us-gaap:PreferredStockMember 2026-03-31 0002044817 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0002044817 mtne:TrustAccountMember 2026-03-31 0002044817 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-08 2026-05-08 0002044817 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2026-05-08 2026-05-08 0002044817 us-gaap:SubsequentEventMember 2026-05-08 2026-05-08 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-08 2026-05-08 0002044817 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2026-05-08 0002044817 us-gaap:SubsequentEventMember 2026-05-08 0002044817 us-gaap:CommonClassAMember 2025-12-31 0002044817 us-gaap:CommonClassBMember 2025-12-31 0002044817 us-gaap:CorporateMember 2025-12-31 0002044817 us-gaap:PreferredStockMember 2025-12-31 0002044817 mtne:PromissoryNoteMember mtne:SponsorMember 2025-12-31 0002044817 mtne:SponsorMember 2025-12-31 0002044817 us-gaap:PreferredStockMember 2025-12-31 0002044817 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-31 0002044817 us-gaap:CommonClassAMember 2026-06-12 0002044817 us-gaap:CommonClassBMember 2026-06-12 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2026-05-04 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember 2026-05-04 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-04 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-04 2026-05-04 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2026-05-04 2026-05-04 0002044817 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-04 2026-05-04 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-05-06 0002044817 mtne:UnitsMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2026-05-06 0002044817 us-gaap:SubsequentEventMember 2026-05-06 0002044817 mtne:SponsorMember 2024-10-24 0002044817 mtne:SponsorMember mtne:FounderSharesMember 2024-10-24 2024-10-24 0002044817 mtne:SponsorMember mtne:FounderSharesMember us-gaap:SubsequentEventMember 2026-04-22 0002044817 mtne:SponsorMember mtne:FounderSharesMember us-gaap:SubsequentEventMember 2026-04-22 2026-04-22 0002044817 mtne:SponsorMember mtne:FounderSharesMember 2025-11-30 0002044817 mtne:FounderSharesMember 2025-11-30 2025-11-30 0002044817 mtne:SponsorMember mtne:FounderSharesMember 2025-11-30 2025-11-30 0002044817 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-12-31 0002044817 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002044817 us-gaap:RetainedEarningsMember 2025-12-31 0002044817 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-03-31 0002044817 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002044817 us-gaap:RetainedEarningsMember 2026-03-31 0002044817 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0002044817 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0002044817 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002044817 us-gaap:RetainedEarningsMember 2024-12-31 0002044817 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0002044817 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0002044817 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002044817 us-gaap:RetainedEarningsMember 2025-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day iso4217:USD xbrli:shares mtne:Segment mtne:Days\n\n \n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n \n\n \n\nFORM\n10-Q\n\n \n\n \n\n \n\n(Mark One)\n\n☒\n\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the quarterly period ended March 31, 2026\n\nOR\n\n \n\n☐\n\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the transition period from\n\n     \n\nto\n\n     \n\nCommission File Number:\n001-43264\n\n \n\n \n\nCH4 Natural Solutions Corporation\n\n(Exact name of registrant as specified in its charter)\n\n \n\n \n\n \n\nCayman Islands\n\n \n\n98-1821196\n\n(State or other jurisdiction of\n\nincorporation or organization)\n\n \n\n(I.R.S. Employer\n\nIdentification No.)\n\n712 Fifth Avenue, 36\nth\nFloor\n\nNew York,\nNY\n\n \n\n10019\n\n(Address of principal executive offices)\n\n \n\n(Zip Code)\n\n(212)\n993-0076\n\n(Registrant’s telephone number, including area code)\n\nNot Applicable\n\n(Former name or former address, if changed since last report)\n\n \n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class\n\n \n\nTrading Symbol(s)\n\n \n\nName of each exchange on which registered\n\nUnits, each consisting of one Class A ordinary share, $0.0001 par value, and\none-half\nof one warrant\n \nMTNE.U\n \nNew York Stock Exchange\n\nClass A ordinary shares, par value $0.0001 per share\n \nMTNE\n \nNew York Stock Exchange\n\nWarrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share\n \nMTNE.WS\n \nNew York Stock Exchange\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation\nS-T\n(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a\nnon-accelerated\nfiler, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule\n12b-2\nof the Exchange Act.\n\n \n\nLarge accelerated filer\n \n☐\n  \nAccelerated filer\n \n☐\n\nNon-accelerated\nfiler\n \n☒\n  \nSmaller reporting company\n \n☒\n\n \n\n  \nEmerging growth company\n \n☒\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the\nextended\ntransition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule\n12b-2\nof the Exchange Act). Yes ☒ No ☐\n\nAs of June 12, 2026, there were 22,200,000 Class A ordinary shares, par value $0.0001 per share, and 7,666,667 Class B ordinary shares, par value $0.0001 per share, issued and outstanding.\n\n \n\n \n\n##### Table of Contents\n\nCH4 NATURAL SOLUTIONS CORPORATION\n\nQuarterly Report on Form 10-Q\n\nTable of Contents\n\n \n\n \n \n \n  \nPage\n \n\n[PART 1 - FINANCIAL INFORMATION](#toc58871_1)"}